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One, two and three-dimensional ultrasound
measurements of carotid atherosclerosis before
and after cardiac rehabilitation: preliminary results
of a randomized controlled trial
Tamas J Lindenmaier1,2, Daniel N Buchanan1,2, Damien Pike1,2, Tim Hartley3, Robert D Reid4, J David Spence1,5,
Richard Chan5, Michael Sharma4, Peter L Prior6, Neville Suskin3,6 and Grace Parraga1,2*
Abstract
Background: It is still not known how patients who are post-transient ischemic attack (TIA) or post-stroke might
benefit from prospectively planned comprehensive cardiac rehabilitation (CCR). In this pilot evaluation of a larger
ongoing randomized-controlled-trial, we evaluated ultrasound (US) measurements of carotid atherosclerosis in subjects
following TIA or mild non-disabling stroke and their relationship with risk factors before and after 6-months of CCR.
Methods: Carotid ultrasound (US) measurements of one-dimensional intima-media-thickness (IMT), two-dimensional
total-plaque-area (TPA), three-dimensional total-plaque-volume (TPV) and vessel-wall-volume (VWV) were acquired
before and after 6-months CCR for 39 subjects who had previously experienced a TIA and provided written
informed consent to participate in this randomized controlled trial. We maintained blinding for this ongoing study
by representing treatment and control groups as A or B, although we did not identify which of A or B was
treatment or control. Carotid IMT, TPA, TPV and VWV were measured before and after CCR as were changes in body
mass index (BMI), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides
(TG), systolic blood pressure (SBP) and diastolic blood pressure (DBP).
Results: There were no significant differences in US measurements or risk factors between groups A and B. There
was no significant change in carotid ultrasound measurements for group A (IMT, p = .728; TPA, p = .629; TPV,
p = .674; VWV, p = .507) or B (IMT, p = .054; TPA, p = .567; TPV, p = .773; VWV, p = .431) at the end of CCR. There were
significant but weak-to-moderate correlations between IMT and VWV (r = 0.25, p = .01), IMT and TPV (r = 0.21,
p = .01), TPV and TPA (r = 0.60, p < .0001) and VWV and TPV (r = 0.22, p = .02). Subjects with improved TC/HDL ratios
showed improved carotid VWV although, this was not statistically significant.
Conclusion: In this preliminary evaluation, there were no significant differences in carotid US measurements in the
control or CCR group; a larger sample size and/or longer duration is required to detect significant changes in US or
other risk factor measurements.
Keywords: Carotid ultrasound, Comprehensive cardiac rehabilitation, Transient ischemic attack, Ischemic stroke,
Three-dimensional ultrasound, Intima-media thickness, Total plaque area, Total plaque volume, Vessel wall volume
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Background
Cerebrovascular diseases are one of the leading causes of
death worldwide and are estimated to account for 10%
of all deaths [1]. In particular, patients who experience a
transient ischemic attack (TIA) are at high risk of stroke
and have increased mortality rates [2]. Nevertheless, evi-
dence from clinical trials indicates that risks of a subse-
quent stroke can be reduced [2] and it is clear that
earlier diagnosis and intervention are critical for lower-
ing both the immediate and ongoing risk.
Carotid ultrasound (US) provides a direct and cost-
effective way to quantify surrogate markers of carotid
atherosclerosis [3-5]. A number of US measurements
have been developed to monitor the progression and re-
gression of atherosclerosis, including one-dimensional
(1D) intima-media thickness (IMT), two-dimensional
(2D) total plaque area (TPA) [5], as well as three-
dimensional ultrasound (3DUS) total plaque volume
(TPV) [6-10] and vessel wall volume (VWV) [7,8,11-15].
Carotid artery IMT has been shown in meta-analyses to
weakly predict ischemic stroke events, while progression
of IMT does not [16,17]. Measurement of carotid plaque
burden using 3DUS carotid TPA or TPV has also been in-
vestigated [18,19] and recently [20] progression of TPV
was shown to be a significant predictor of outcomes such
as TIA, stroke, myocardial infarction and death, whereas
progression of IMT was not.
A feasibility study of the effect of comprehensive car-
diac rehabilitation (CCR) on patients with a recent TIA
or mild non-disabling stroke (MNDS) [21] showed sig-
nificant improvements after 6 months CCR in total
cholesterol (TC), total cholesterol/low-density lipopro-
tein (TC/LDL), triglycerides (TG), waist circumference
(WC), body mass index (BMI) and body weight. There
was also a trend towards improved low-density lipo-
protein (LDL), systolic blood pressure (SBP) and dia-
stolic blood pressure (DBP) [21]. Unanswered research
questions stemming from this important pilot study
remain: 1) Does carotid atherosclerosis change during
6 month CCR?, 2) Are potential changes in carotid
plaque over the course of CCR correlated with changes
in serum biomarkers?, and, 3) Do baseline carotid
ultrasound measurements predict changes in US and
other risk factors after 6–months CCR?
Our objective was to investigate carotid ultrasound
measurements of atherosclerosis in one, two and three-
dimensions in a small group of subjects, before and after
6 months of CCR, to evaluate changes over time and to
explore potential correlations between stroke risk factors
and carotid US measurements. In this proof –of-concept
study, our overarching hypothesis was that CCR inter-
vention slowed atherosclerosis progression. Here we dir-
ectly tested the hypothesis that after 6-months CCR,
there would be significantly improved US measurements
of carotid atherosclerosis in subjects with improved
cardiovascular risk, measured using their serum lipid
profile.
Methods
Inclusion and exclusion criteria
All thirty-nine subjects provided written informed con-
sent to 3DUS as part of an ongoing, two-site (London,
n = 60 and Ottawa, n = 37) randomized controlled trial
of 6-months of CCR following TIA. The study protocol
was approved by Health Sciences Research Ethics Board,
The University of Western Ontario London Canada.
Briefly, subjects with a documented TIA or a MNDS
within the previous 3 months were recruited. Subjects
were at least 20 years of age, spoke and understood
English, and also had one or more of the following risk
factors: hypertension, diabetes mellitus, dyslipidemia,
ischemic heart disease or cigarette smoking within the
past year. In addition, subjects who were unable to
perform CCR exercises or had already participated in
CCR were not enrolled. Subjects were excluded from
analyses if they did not have carotid US images with
sufficient image quality to perform IMT, TPA, TPV or
VWV measurements.
Intervention
A detailed description of the CCR intervention was pre-
viously reported [21]. Briefly, a two-hour orientation ses-
sion led by a nurse case manager was undertaken for
subjects who provided consent [21]. The orientation ses-
sion provided risk factor education, screening with the
Hospital Anxiety & Depression Scale [22] and a quality
of life evaluation using the SF-12 Health Survey [23].
Subjects were also advised on smoke cessation and after
a 12 hour overnight fast, tested for lipids and fasting
blood glucose [21]. Prior to CCR, medical and risk factor
assessment was performed [21] and subjects were pro-
vided a choice of CCR intervention -on-site exercise
twice weekly for 50 sessions with complementary in-
home exercise at least 2 days a week, or in-home exer-
cise at least 4 days a week with monthly follow-up by
telephone or on-site [21].
Data acquisition
Carotid artery 3DUS was acquired with a high resolution
B-mode ultrasound system (ATL HDI 5000; Philips,
Bothel, WA, USA) and an 8.5 MHz transducer (Philips)
at the Stroke Prevention & Atherosclerosis Research
Centre in London, Canada as previously described [24].
To briefly summarize, the US transducer was manually
placed on the neck and then moved along a 5 cm section
of the neck mechanically, acquiring a series of 2D im-
ages that were reconstructed into a 3D volume. To ob-
tain high quality images, the sonographer optimized the
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imaging parameters of the system for each subject inde-
pendently. At baseline (BL) and follow-up (FU), 3DUS
volumes of the left and right carotid artery were ac-
quired and archived for measurements made offline.
Intima media thickness
IMT measurements (ICC = 0.95) [7] were performed by
a single observer as previously described [4]. A single
observer who was blinded to subject identity and time-
point generated a single 2D longitudinal view of the ca-
rotid artery from the 3DUS image. The resultant 2D
image was segmented and evaluated using Prowin 24.0
(Medical Technologies International Inc, Palm Desert,
CA, USA) previously developed and validated [25].
IMT was measured five times for each carotid side and
the mean measurements were averaged to provide a
value for the left and right carotid artery for each
subject.
3DUS Total plaque area
TPA measurements were generated in real-time by an
experienced sonographer (ICC = 0.94) [5] at the time of
the 3DUS image acquisition using the trackball of the
ultrasound system as previously described [5]. Briefly,
the transducer was positioned to obtain a longitudinal
view of the plaque at its greatest footprint in the image
volume. The outer boundaries of each individual plaque
was segmented manually in that plane and all plaque
areas were summed to generate a TPA measurement for
the left and right carotid artery for each subject. The so-
nographer was blinded to treatment status and previous
TPA measurements at the follow-up scanning session.
3DUS Total plaque volume
A single observer (the same for IMT, TPV and VWV)
also generated TPV (ICC = 0.85) [8] for BL and FU im-
ages. Randomized and blinded BL and FU images were
simultaneously displayed on adjacent monitors to ensure
identification of the same plaque in images at both time-
points. For the generation of TPV measurements, custom-
built software tools previously described [26] were used for
evaluation of carotid plaque identified within 10 mm distal
to the bifurcation in the common carotid artery (CCA)
and 5 mm proximal to the BF in the internal carotid artery
(ICA). TPV for each individual was calculated by summing
the volume of individual plaques within the left and right
carotid arteries.
3DUS Vessel wall volume
The same single observer evaluated blinded BL and FU
images for 3DUS VWV using a semi-automated segmen-
tation method (ICC = 0.95) [8], previously described
[15]. Briefly, the media-adventitia boundary (MAB) and
the lumen-intima boundary (LIB) were manually seg-
mented in 11 slices of the CCA and 6 slices of the ICA
with an inter-slice distance of 1 mm [24]. Using the
inter-slice distance and the areas enclosed by the MAB
and LIB in each slice, the volumes between slices were
calculated. Measurements of the left and right sides were
summed together to obtain a VWV for each individual.
Statistical analysis
Since our analysis is part of a larger ongoing randomized
control trial, the CCR and control subject data were kept
blinded and named as group A or B in order to elimin-
ate the potential for bias in future analyses. Statistical
Table 1 Study subject baseline characteristics
All evaluated
Evaluated by group
Group A Group B p
n Mean (SD) n Mean (SD) n Mean (SD)
Age year (±SD) 39 65 (10) 19 64 (10) 20 66 (11) 1.00
BMI kg/m2 (±SD) 39 28 (4) 19 29 (4) 20 26 (4) 0.07
TC mmol/L (±SD) 39 4.24 (1.23) 19 4.10 (1.13) 20 4.37 (1.33) 1.00
HDL mmol/L (±SD) 39 1.34 (0.46) 19 1.29 (0.35) 20 1.38 (0.55) 1.00
LDL mmol/L (±SD) 39 2.28 (0.97) 19 2.21 (0.95) 20 2.35 (1.00) 1.00
TG mmol/L (±SD) 39 1.35 (0.67) 19 1.29 (0.52) 20 1.41 (0.79) 1.00
SBP mmHg (±SD) 39 125 (13) 19 124 (14) 20 125 (11) 0.99
DBP mmHg (±SD) 39 74 (10) 19 77 (10) 20 71 (10) 0.41
IMT mm (±SD) 36 0.762 (0.133) 17 0.785 (0.121) 19 0.742 (0.142) 1.00
TPA cm2 (±SD) 36 1.12 (1.25) 19 1.05 (1.64) 17 1.19 (0.64) 1.00
TPV mm3 (±SD) 32 100 (101) 14 55 (60) 18 137 (115) 0.20
VWV mm3 (±SD) 29 929 (193) 13 972 (234) 16 894 (152) 1.00
BMI = body mass index; TC = total cholesterol; HDL = high density lipoprotein; LD = low density lipoprotein; TG = triglycerides; SBP = systolic blood pressure;
DBP = diastolic blood pressure; IMT = intima-media thickness; TPA = total plaque area; TPV = total plaque volume; VWV = vessel wall volume.
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Table 2 Subject summary
Sub.
num. Group Sex
Age
yrs
BMI BL
kg/m2
TC BL
mmol/L
TG BL
mmol/L
HDL BL
mmol/L
LDL BL
mmol/L
SBP BL
mmHg
DBP BL
mmHg
IMT BL
mm
IMT FU
mm
TPA BL
cm2
TPA FU
cm2
TPV BL
mm3
TPV FU
mm3
VWV BL
mm3
VWV FU
mm3
1 A M 54 32.5 4.8 0.71 1.5 2.98 124 80 0.670 0.644 0.00 0.00 0 0 1040 1006
2 B M 59 29.1 4.0 2.50 0.8 2.12 122 76 0.655 0.62 0.92 0.73 106 132 846 725
3 B F 45 24.2 4.9 0.70 2.2 2.40 146 82 0.658 0.728 0.03 0.03 23 0 591 613
4 A F 61 24.9 3.6 0.58 2.0 1.37 112 80 0.641 0.705 0.15 0.10 26 25 776 789
5 B F 60 33.8 3.9 1.17 0.8 2.51 118 62 0.526 0.622 1.37 n/a 135 130 906 912
6 A M 56 30.6 3.9 1.75 1.0 2.03 128 78 0.762 0.679 1.41 1.75 n/a n/a n/a n/a
7 A F 63 32.7 6.5 2.18 1.4 4.17 130 80 n/a n/a 0.29 0.26 n/a n/a n/a n/a
8 B F 41 19.8 6.4 0.80 2.4 3.59 110 50 0.514 0.536 0.29 0.33 0 0 709 670
9 B M 61 27.9 6.1 1.98 1.5 3.72 140 80 n/a n/a 1.98 1.97 n/a n/a n/a n/a
10 B M 77 21.8 3.5 0.59 1.4 1.79 139 58 0.953 0.932 1.24 1.68 479 472 1007 1055
11 A M 68 29.5 4.0 1.88 1.0 2.11 150 76 0.969 0.86 0.52 0.61 100 83 1534 1548
12 B F 82 27.4 4.7 1.44 1.8 2.24 120 70 0.792 0.847 1.22 1.30 132 150 786 936
13 A M 71 27.6 5.0 0.99 2.2 2.43 150 86 0.902 0.855 1.52 1.47 115 82 985 1030
14 B F 69 27.4 5.2 1.83 1.4 2.94 122 56 0.740 0.894 n/a 1.61 137 156 1206 1215
15 B F 73 22.3 4.5 1.39 1.6 2.26 136 80 0.606 0.732 0.53 0.39 24 17 n/a n/a
16 A M 51 24.3 4.7 1.09 1.3 2.93 118 80 0.657 0.651 0.11 0.09 0 0 976 916
17 A F 75 33.6 3.1 1.82 1.1 1.18 122 66 0.804 0.666 0.13 0.38 0 0 1112 1089
18 B M 64 29.7 6.0 3.84 1.3 2.93 140 68 0.720 0.956 1.58 n/a 154 122 1112 1023
19 B M 64 29.0 5.4 2.25 0.8 3.55 118 76 0.829 0.669 0.94 0.98 9 14 876 924
20 A F 66 34.3 4.6 0.99 1.3 2.79 110 75 0.865 0.744 0.32 0.35 n/a n/a n/a n/a
21 A M 56 32.0 4.2 0.81 1.3 2.51 110 80 0.655 0.671 0.29 0.30 107 92 1172 1187
22 B M 68 28.4 5.2 1.06 0.9 3.83 124 82 0.669 0.757 1.53 1.84 189 208 868 807
23 A M 68 28.1 4.9 2.05 0.9 3.01 140 90 0.736 0.851 0.61 0.51 0 0 815 848
24 A M 75 28.3 2.7 1.20 0.9 1.29 115 61 0.834 0.926 1.91 2.41 n/a n/a n/a n/a
25 B F 77 20.5 4.8 0.81 2.4 2.02 118 60 0.662 0.636 1.76 1.39 192 185 1006 1069
26 A F 82 31.5 6.0 1.61 1.5 3.77 142 84 n/a n/a 0.38 0.31 0 0 1074 1104
27 A M 52 26.0 4.5 1.61 1.7 2.04 130 90 0.740 0.81 0.92 0.78 29 30 n/a n/a
28 A M 62 24.1 2.0 1.32 1.0 0.30 104 50 0.942 0.925 7.37 6.60 n/a n/a n/a n/a
29 B M 71 23.9 2.4 0.60 1.0 1.10 130 80 0.949 1.107 2.24 2.18 n/a n/a n/a n/a
30 A F 57 34.0 3.1 0.64 1.1 1.69 120 80 0.999 0.904 0.98 1.11 57 86 688 737
31 B M 61 27.4 1.9 0.72 0.7 0.82 110 80 0.718 0.822 1.06 1.00 217 254 834 889
32 A M 80 21.9 2.7 0.76 1.3 1.07 100 70 0.661 0.687 1.64 1.47 176 180 702 629
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Table 2 Subject summary (Continued)
33 B F 80 20.5 2.6 0.88 1.3 0.85 110 60 1.044 0.914 0.79 0.48 17 26 774 814
34 B M 77 26.4 3.0 1.20 1.4 0.97 110 70 0.902 0.823 1.38 0.91 215 205 917 953
35 B M 59 24.8 2.7 1.40 0.8 1.28 128 76 0.770 0.829 1.04 0.65 97 81 1015 948
36 A M 61 28.9 3.8 0.79 1.3 2.14 130 80 0.847 0.973 1.16 1.71 132 135 1005 829
37 A F 50 32.1 3.9 1.66 1.0 2.18 130 80 0.658 0.669 0.27 0.37 27 34 752 765
38 B M 65 30.2 5.1 1.40 2.1 2.36 124 78 0.685 0.823 0.89 0.91 103 107 851 996
39 B M 63 20.8 5.4 1.62 1.0 3.64 126 66 0.712 0.778 2.36 2.79 238 228 n/a n/a
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analysis was performed using IBM SPSS Statistics for
Windows v20 (IBM Corp, Armonk, NY, USA 2011) and
GraphPad Prism for Windows, v6.02 (GraphPad Soft-
ware, La Jolla, CA, USA). The Shapiro-Wilk test was
used to assess for normality of samples. Student’s para-
metric t-tests were performed to assess baseline differ-
ences between groups A and B, to detect any differences
between BL and FU ultrasound measurements, and to
detect any differences in US measurements between
groups A and B after the treatment period. In the case
of non-parametric samples, the Mann–Whitney test was
used to assess differences. Changes in plaque burden
over the course of CCR, regardless of group assignment,
were determined for subjects with an improved lipid
profile using Student’s t-test, and Spearman correlations
between carotid plaque burden and risk factors were
Figure 1 Carotid Atherosclerosis Measurements for Three Representative Subjects. Baseline and 6 month follow-up for intima media
thickness (left column), total plaque volume (middle column), and vessel wall volume (right column). Scalar bar = 1 cm. Subject 1 is a 68-year-old
male from Group A; R carotid artery baseline IMT = 1.044 mm, TPV = 100 mm3, VWV = 710 mm3 and follow-up IMT = 0.862 mm, TPV = 80 mm3,
VWV = 720 mm3. Subject 2 is a 77-year-old male from Group B with R carotid artery baseline IMT = 0.895 mm, TPV = 70 mm3, VWV = 390 mm3 and
follow-up IMT = 0.790 mm, TPV = 70 mm3, VWV = 420 mm3. Subject 3, from Group B is a 61 year old male; R Carotid artery IMT = 0.744 mm,
TPV = 170 mm3, and VWV = 430 mm3 at baseline and IMT = 0.882 mm, TPV = 200 mm3 and VWV = 470 mm3 at follow-up.
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determined. Results were considered significant when
the probability of making a type I error was less than
5% (p < .05). The Holm-Bonferroni correction was used
for multiple comparisons.
Results
Subject characteristics
Table 1 provides a summary of the baseline study char-
acteristics for all 39 enrolled subjects. In Table 2, a sub-
ject listing for all 39 subjects is provided with BL and
FU ultrasound and demographic measurements. Mean
age was 65 ± 10 years, and there were no significant dif-
ferences between group A and group B. The CCR and
control therapy period was 223 (±66) days.
Carotid ultrasound measurements
Figure 1 shows carotid artery IMT, TPV, and VWV im-
ages and measurements for three representative subjects
at BL and after six months FU. Subject 1 is a 68 year old
male from group A with decreased right carotid artery
IMT (0.182 mm) and TPV (20 mm3), but a slightly in-
creased VWV (10 mm3). Subject 2, is a 77 year old male
from group B with minimal changes in TPV and VWV
of the right carotid over the CCR period. In contrast
Subject 3, a 61 year old male from group B, showed
an increase in right carotid IMT (0.138 mm), TPV
(30 mm3) and VWV (40 mm3).
Table 3 summarizes the BL and FU carotid ultrasound
measurements for groups A and B; there were no significant
Table 3 Baseline and follow-up carotid ultrasound measurements
Measurement
(±SD)
Group A Group B
n BL FU Total diff. p n BL FU Total diff. p
IMT (mm) 17 0.785 (0.121) 0.778 (0.115) −0.007 (0.083) 0.728 19 0.742 (0.142) 0.791 (0.140) 0.048 (0.103) 0.054
TPA (cm2) 19 1.05 (1.64) 1.08 (1.50) 0.03 (0.28) 0.629 17 1.19 (0.64) 1.15 (0.74) −0.04 (0.27) 0.567
TPV (mm3) 14 55 (60) 53 (57) −2 (14) 0.674 18 137 (115) 138 (116) 1 (18) 0.773
VWV (mm3) 13 972 (234) 960 (241) −12 (62) 0.507 16 894 (152) 909 (156) 15 (76) 0.431
TPA = total plaque area; IMT = intima media thickness; TPV = total plaque volume; VWV = vessel wall volume; BL = baseline; FU = follow-up.
Total IMT is calculated by taking the mean between the left (L) and right (R) sides. Total TPA, TPV and VWV is the sum of the L and R sides.
Figure 2 Relationships for Carotid Ultrasound Measurements. Panels A-D show relationships for ultrasound (US) measurements in 39
subjects, including intima-media thickness (IMT), total plaque area (TPA), total plaque volume (TPV) and vessel wall volume (VWV) for Left and
Right carotids at baseline and follow-up. Panel A and B show the association of IMT with VWV and TPV. Panel C shows relationship of TPV with
TPA and panel D shows the association between VWV and TPV.
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differences for IMT, TPA, TPV and VWV after CCR. In
Figure 2, correlations are shown for ultrasound measure-
ments for all subjects. Modest but significant correlations
were observed for VWV and IMT (r = 0.25, p = .01), TPV
and IMT (r = 0.21, p = .01), TPV and TPA, (r = 0.60,
p < .0001) and finally for VWV and TPV (r = 0.22, p = .02)
for all left and right carotid sides. There were similar find-
ings for right (R) (VWV and IMT, r = 0.36, p = .01; TPV and
IMT, r = 0.28, p = .02; TPV and TPA, r = 0.61, p < .0001;
VWV and TPV, r = 0.27, p = .04), and left (L) (TPA and
TPV; r = 0.68, p < .0001) carotid artery measurements. Sig-
nificant correlations were also observed for all males only
between TPV and TPA (r = 0.56, p < .0001). For fe-
males only, significant correlations were also observed be-
tween TPV and TPA (r = 0.83, p < .0001) and between
VWV and TPV(r = 0.47, p = .001).
Risk factors and carotid US measurements
Table 4 provides a summary of baseline carotid ultrasound
measurements correlations with their change and the
change in risk factors after completion of the 6-month
treatment period. There were no significant correlations
between any of the US measurements and change in risk
factors. As shown in Table 5, there were no significant
correlations for the change in US measurements and the
change in risk factors. Furthermore, as shown in Table 6
there were no significant differences for the change in US
measurements over time, between subjects with improved
and unchanged TC/HDL ratios.
Discussion
Our goal was to investigate the potential changes in
carotid atherosclerosis in subjects who had enrolled in
a randomized controlled trial of six month CCR post-
TIA [21]. We showed: 1) there were no significant
changes in IMT, TPA, TPV and VWV in group A and
B, and there were no significant differences in US mea-
surements between groups A and B before or after
therapy, 2) there were no significant correlations be-
tween baseline US measurements and the change in
Table 4 Relationships for baseline US measurements and risk factors
Risk factors IMT (mm) TPA (cm2) TPV (mm3) VWV (mm3)
n r p n r p n r p n r p
Group A
Δ IMT (mm) 17 −0.44 0.88 17 0.23 1.00 13 0.17 1.00 12 −0.30 1.00
Δ TPA (cm2) 17 0.24 1.00 19 −0.10 1.00 14 0.06 0.85 13 0.24 1.00
Δ TPV (mm3) 13 0.08 0.79 14 0.22 1.00 14 0.07 1.00 13 −0.64 0.15
Δ VWV (mm3) 12 0.34 1.00 13 0.25 1.00 13 −0.10 1.00 13 −0.04 0.91
Δ BMI (kg/m2) 16 −0.15 1.00 18 0.35 1.00 13 0.27 1.00 12 −0.21 1.00
Δ TC (mmol/L) 16 0.25 1.00 18 0.31 1.00 13 0.09 1.00 12 −0.45 1.00
Δ HDL (mmol/L) 16 0.20 1.00 18 0.39 1.00 13 0.26 1.00 12 −0.34 1.00
Δ LDL (mmol/L 16 0.11 1.00 18 0.06 0.82 13 −0.15 1.00 12 −0.29 1.00
Δ TG (mmol/L) 16 0.30 1.00 18 0.46 0.58 13 0.40 1.00 12 −0.21 1.00
Δ SBP (mmHg) 16 −0.10 1.00 18 −0.10 1.00 13 −0.14 1.00 12 −0.12 1.00
Δ DBP (mmHg) 16 0.13 1.00 18 −0.06 1.00 13 −0.32 1.00 12 0.63 0.30
Group B
Δ IMT (mm) 19 −0.21 1.00 16 0.06 1.00 18 0.18 1.00 16 0.26 1.00
Δ TPA (cm2) 16 −0.01 0.98 17 0.13 1.00 15 0.20 1.00 13 −0.18 1.00
Δ TPV (mm3) 18 0.01 1.00 15 0.04 0.88 18 −0.01 0.96 16 −0.31 1.00
Δ VWV (mm3) 16 0.35 1.00 13 0.22 1.00 16 0.14 1.00 16 −0.22 1.00
Δ BMI (kg/m2) 19 −0.33 1.00 17 −0.54 0.30 18 −0.52 0.29 16 −0.06 1.00
Δ TC (mmol/L) 19 −0.18 1.00 17 0.15 1.00 18 0.28 1.00 16 −0.01 0.99
Δ HDL (mmol/L) 19 0.20 1.00 17 0.06 1.00 18 −0.08 1.00 16 0.03 1.00
Δ LDL (mmol/L 19 −0.30 1.00 17 0.06 1.00 18 0.24 1.00 16 −0.01 1.00
Δ TG (mmol/L) 19 −0.24 1.00 17 0.16 1.00 18 0.34 1.00 16 −0.01 1.00
Δ SBP (mmHg) 19 0.05 1.00 17 0.14 1.00 18 0.14 1.00 16 −0.07 1.00
Δ DBP (mmHg) 19 −0.33 1.00 17 −0.10 1.00 18 0.02 1.00 16 0.27 1.00
BMI = body mass index; TC = total cholesterol; HDL = high density lipoprotein; LDL = low density lipoprotein; TG = triglycerides; SBP = systolic blood pressure;
DBP = diastolic blood pressure; IMT = intima-media thickness; TPA = total plaque area; TPV = total plaque volume; VWV = vessel wall volume; Δ, Delta = FU-BL.
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risk factors and, 3) there were no statistically signifi-
cant differences in the change in US measurements be-
tween subjects with an improved and unchanged TC/
HDL ratio.
First, we observed no significant changes in carotid
ultrasound measurements of atherosclerosis in either
groups A or B after 6 months of therapy. We note that a
previous study [12] in a small group of 30 patients
showed a significantly decreased TPV in high risk stroke
subjects who administered 3-months intensive atorva-
statin therapy as compared to those who received pla-
cebo. Another dietary intervention study also showed
significant 2-year changes in 3DUS VWV a larger group
of 140 subjects [14]. The fact that there were no signifi-
cant changes in IMT, TPV or VWV here suggests that
an extended period of CCR or perhaps a larger sample
size is required to detect differences in carotid athero-
sclerosis measurements. Previous work that showed sig-
nificant improvements in serum and other stroke risk
factors [21] after 6 months CCR (although not con-
trolled) also suggests that improvements in carotid
atherosclerosis may require a longer time-frame or
perhaps a larger sample size to detect.
As might be expected, we observed significant and
modestly strong correlations between the 1D, 2D and
3D carotid ultrasound measurements. These results were
similar to previous findings in different patient popula-
tions [24] and suggest that changes in IMT and TPA ex-
plain some of the variability in carotid TPV and VWW.
This is not unexpected because TPV is in essence a 3D
TPA measurement and VWV is essentially a 3D IMT +
plaque measurement. It is also worth noting that there
were significant linear correlations for male and female
measurements when considered independently. These
findings strengthen the conclusions derived from previ-
ous work [24] where a significant but weak correlation
for TPV and VWV was observed in females.
Total cholesterol (TC) to high-density lipoprotein (HDL)
cholesterol ratios are commonly used for evaluating the
risk of stroke and can be used as predictors of peripheral
arterial disease [27]. For the small number of subjects with
improved TC:HDL ratio (n = 24), regardless of treatment
Table 6 Changes in US measurements for subjects with
improved and unchanged TC/HDL
Ultrasound
measurements
Improved TC/HDL Not improved TC/HDL p
n Mean (SD) n Mean (SD)
ΔIMT (mm) 23 0.001 (0.110) 12 0.065 (0.051) 0.28
ΔTPA (cm2) 22 0 (0.25) 13 0 (0.33) 0.87
ΔTPV (mm3) 20 1 (18) 11 −1(12) 1.00
ΔVWV (mm3) 19 −9 (67) 9 37 (73) 1.00
BL = baseline; FU = follow-up; IMT = intima-media thickness; TPA = total plaque
area; TPV = total plaque volume; VWV = vessel wall volume; TC = total
cholesterol; HDL = high density lipoprotein; Δ, Delta = FU-BL.
Table 5 Relationship between change in ultrasound measurements and change in risk factors
Change in risk
factors
ΔIMT (mm) ΔTPA (cm2) ΔTPV (mm3) ΔVWV (mm3)
r p r p r p r p
Group A
n = 16 n = 18 n = 13 n = 12
Δ BMI (kg/m2) 0.48 0.45 0.27 1.00 0.21 0.99 0.16 1.00
Δ TC (mmol/L) −0.10 0.71 0.00 1.00 0.33 1.00 0.19 1.00
Δ HDL (mmol/L) −0.23 1.00 0.13 1.00 0.46 0.81 0.07 1.00
Δ LDL (mmol/L −0.18 1.00 0.14 1.00 0.21 1.00 0.17 1.00
Δ TG (mmol/L) 0.21 1.00 −0.03 1.00 0.06 0.85 0.28 1.00
Δ SBP (mmHg) −0.19 1.00 −0.11 1.00 0.28 1.00 −0.04 0.91
Δ DBP (mmHg) −0.39 0.83 0.06 1.00 −0.44 0.71 −0.12 1.00
Group B
n = 19 n = 17 n = 18 n = 16
Δ BMI (kg/m2) −0.19 1.00 −0.26 1.00 0.02 1.00 −0.17 1.00
Δ TC (mmol/L) 0.23 1.00 −0.11 1.00 −0.21 1.00 −0.30 0.76
Δ HDL (mmol/L) 0.15 1.00 −0.08 1.00 0.02 0.95 −0.31 0.95
Δ LDL (mmol/L 0.25 1.00 −0.23 1.00 −0.30 1.00 −0.35 0.92
Δ TG (mmol/L) 0.14 1.00 0.30 1.00 −0.05 1.00 0.11 0.69
Δ SBP (mmHg) 0.02 0.93 −0.46 0.44 0.05 1.00 0.40 0.74
Δ DBP (mmHg) 0.55 0.11 0.06 0.82 −0.46 0.38 −0.44 0.60
BMI = body mass index; TC = total cholesterol; HDL = high density lipoprotein; LDL = low density lipoprotein; TG = triglycerides; SBP = systolic blood pressure;
DBP = diastolic blood pressure; IMT = intima-media thickness; TPA = total plaque area; TPV = total plaque volume; VWV = vessel wall volume; Δ, Delta = FU-BL.
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group, there were no significant differences and this sug-
gests that a larger sample size may be needed to show sig-
nificant improvement in US measurements after 6 months
therapy.
It is important to note the rationale for including carotid
ultrasound imaging in this randomized controlled trial.
While a previous study of the effects of CCR evaluated
risk factors and plasma lipid biomarkers [21] and showed
modest effects, carotid US measurements of atheroscler-
osis were included here to try to determine the direct ef-
fects of CCR on carotid artery media hypertrophy, intima
thickening and atherosclerotic plaque. Carotid US mea-
surements provide a robust, rapid and relatively inexpen-
sive way to generate non-invasive measurements of the
direct determinants of stroke and TIA risk.
We must acknowledge a number of study limitations.
First, this was a small pilot study, involving only subjects
who consented to US monitoring (39 in total) and of
these, there were subjects with incomplete imaging data,
mainly due to insufficient image quality to complete
quantitative analysis for some of the US data. As previ-
ously described [21], subjects were also provided a choice
between two exercise treatments. We think that this
choice of treatment may have had an effect on outcomes,
including results obtained from carotid ultrasound
measurements. Among the different ultrasound mea-
surements, we believe that VWV would be a strong
candidate in monitoring atherosclerotic disease over
time in individuals performing CCR. It offers a wide
dynamic range and it provides information about the
arterial wall thickness as well as any plaque that may
be present in the area of interest around the bifur-
cation of the carotid artery. Future studies may be re-
quired with a larger number of subjects or perhaps a
longer follow-up study to measure and follow stroke
risk factors and 3DUS measurements. Further studies
can be performed to evaluate how patients who have
not yet experienced a stroke but are at high risk would
respond to comprehensive cardiac rehabilitation. We
would hypothesize an improved quality of life and risk
factors, including those related to carotid atheroscler-
osis decreasing the likelihood of a stroke.
Conclusions
We observed no significant difference in carotid US
measurements of IMT, TPA, TPV and VWV within or
between the two groups (A and B), after the 6-month
evaluation period. A longer therapy period with an in-
creased sample size may be required to show significant
changes in US measurements in this patient population
and after CCR.
Abbreviations
1D: One-dimensional; 2D: Two-dimensional; 3D: Three-dimensional;
3DUS: Three-dimensional ultrasound; BF: Bifurcation; BL: Baseline;
BMI: Body mass index; CCA: Common carotid artery; CCR: Comprehensive
cardiac rehabilitation; DBP: Diastolic blood pressure; FU: Follow-up;
HDL: High density lipoprotein; ICA: Internal carotid artery; IMT: Intima-media
thickness; L: Left; LDL: Low density lipoprotein; LIB: Lumen-intima boundary;
MAB: Media-adventitia boundary; R: Right; SBP: Systolic blood pressure;
TC: Total cholesterol; TG: Triglycerides; TIA: Transient ischemic attack;
TPA: Total plaque area; TPV: Total plaque volume; US: Ultrasound;
VWV: Vessel wall volume.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
TJL performed IMT, TPV and VWV measurements, presented and analyzed
the data, and wrote the first draft of the manuscript. DB acquiring patient
demographics and managed the patient information database, edited drafts
of the manuscript and approved it. DP contributed to the analysis and
revision of the manuscript. TH provided subject demographics and
ultrasound images for the subjects involved in the study. NS, JDS, RDR, RC
and MS generated the hypotheses and study concepts and reviewed and
revised manuscript drafts. PLP reviewed the manuscript and generated
hypotheses and study concepts for the RCT. GP, the corresponding author,
supervised the data analysis and revised the manuscript. All authors
approved of the manuscript.
Acknowledgements
The authors thank the London Health Science Centre/St. Joseph Hospital
Cardiac Rehabilitation & Secondary Prevention Program and all our
collaborators. N. Suskin acknowledges support of an HSFC Operating Grant
(NA6151). G. Parraga acknowledges support of a CIHR New Investigator
Award.
Author details
1Imaging Research Laboratories, Robarts Research Institute, 1151 Richmond St,
London, ON N6A 5B7, Canada. 2Department of Medical Biophysics, The
University of Western Ontario, London, Canada. 3Division of Cardiology,
Department of Medicine, The University of Western Ontario, London, Canada.
4Division of Prevention and Rehabilitation, University of Ottawa Heart Institute,
Ottawa, Canada. 5Department of Clinical Neurological Sciences, The University
of Western Ontario, London, Canada. 6Cardiac Rehabilitation and Secondary
Prevention, St. Joseph’s Hospital, London, Canada.
Received: 9 October 2013 Accepted: 4 November 2013
Published: 6 November 2013
References
1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and
regional burden of disease and risk factors, 2001: systematic analysis of
population health data. Lancet 2006, 367:1747–1757.
2. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB,
Gorelick P, Halperin J, Harbaugh R, et al: Guidelines for prevention of
stroke in patients with ischemic stroke or transient ischemic attack: a
statement for healthcare professionals from the American heart
association/American stroke association council on stroke: co-sponsored
by the council on cardiovascular radiology and intervention: the Ameri-
can academy of neurology affirms the value of this guideline. Circulation
2006, 113:e409–e449.
3. Barth JD: An update on carotid ultrasound measurement of intima-media
thickness. Am J Cardiol 2002, 89:32B–38B. discussion 38B-39B.
4. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R: Intimal plus medial
thickness of the arterial wall: a direct measurement with ultrasound
imaging. Circulation 1986, 74:1399–1406.
5. Spence JD, Eliasziw M, DiCicco M, Hackam DG, Galil R, Lohmann T: Carotid
plaque area: a tool for targeting and evaluating vascular preventive
therapy. Stroke; a Journal of Cerebral Circulation 2002, 33:2916–2922.
6. Al-Shali K, House AA, Hanley AJ, Khan HM, Harris SB, Mamakeesick M,
Zinman B, Fenster A, Spence JD, Hegele RA: Differences between carotid
wall morphological phenotypes measured by ultrasound in one, two
and three dimensions. Atherosclerosis 2005, 178:319–325.
7. Egger M, Krasinski A, Rutt BK, Fenster A, Parraga G: Comparison of
B-mode ultrasound, 3-dimensional ultrasound, and magnetic
Lindenmaier et al. Cardiovascular Ultrasound 2013, 11:39 Page 10 of 11
http://www.cardiovascularultrasound.com/content/11/1/39
resonance imaging measurements of carotid atherosclerosis.
J Ultrasound Med: Official Journal of the American Institute of
Ultrasound in Medicine 2008, 27:1321–1334.
8. Egger M, Spence JD, Fenster A, Parraga G: Validation of 3D ultrasound
vessel wall volume: an imaging phenotype of carotid atherosclerosis.
Ultrasound Med Biol 2007, 33:905–914.
9. Pollex RL, Spence JD, House AA, Fenster A, Hanley AJ, Zinman B, Harris SB,
Hegele RA: A comparison of ultrasound measurements to assess carotid
atherosclerosis development in subjects with and without type 2
diabetes. Cardiovasc Ultrasound 2005, 3:15.
10. Riccio SA, House AA, Spence JD, Fenster A, Parraga G: Carotid
ultrasound phenotypes in vulnerable populations. Cardiovasc
Ultrasound 2006, 4:44.
11. Egger M, Chiu B, Spence JD, Fenster A, Parraga G: Mapping spatial and
temporal changes in carotid atherosclerosis from three-dimensional
ultrasound images. Ultrasound Med Biol 2008, 34:64–72.
12. Krasinski A, Chiu B, Spence JD, Fenster A, Parraga G: Three-dimensional
ultrasound quantification of intensive statin treatment of carotid
atherosclerosis. Ultrasound Med Biol 2009, 35:1763–1772.
13. Mallett C, House AA, Spence JD, Fenster A, Parraga G: Longitudinal
ultrasound evaluation of carotid atherosclerosis in one, two and three
dimensions. Ultrasound Med Biol 2009, 35:367–375.
14. Shai I, Spence JD, Schwarzfuchs D, Henkin Y, Parraga G, Rudich A, Fenster A,
Mallett C, Liel-Cohen N, Tirosh A: Dietary intervention to reverse carotid
atherosclerosis. Circulation 2010, 121:1200–1208.
15. Ukwatta E, Awad J, Ward A, Buchanan D, Samarabandu J, Parraga G, Fenster
A: Three-dimensional ultrasound of carotid atherosclerosis:
Semiautomated segmentation using a level set-based method. Med Phys
2011, 38:2479.
16. Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans
MJ, Engström G, Evans GW, de Graaf J, Grobbee DE: Common carotid
intima-media thickness measurements in cardiovascular risk PredictionA
meta-analysisCarotid intima-media thickness and risk prediction. JAMA
2012, 308:796–803.
17. Lorenz MW, Polak JF, Kavousi M, Mathiesen EB, Völzke H, Tuomainen T-P,
Sander D, Plichart M, Catapano AL, Robertson CM: Carotid intima-media
thickness progression to predict cardiovascular events in the general
population (the PROG-IMT collaborative project): a meta-analysis of
individual participant data. Lancet 2012, 379:2053–2062.
18. Spence JD: Carotid plaque measurement is superior to IMT: invited
editorial comment on: carotid plaque, compared with carotid
intima-media thickness, more accurately predicts coronary artery disease
events: a meta-analysis—Yoichi Inaba, MD, Jennifer A. Chen MD,
Steven R. Bergmann MD, Ph. D. Atherosclerosis 2012, 220:34–35.
19. Inaba Y, Chen JA, Bergmann SR: Carotid plaque, compared with carotid
intima-media thickness, more accurately predicts coronary artery disease
events: a meta-analysis. Atherosclerosis 2012, 220:128–133.
20. Wannarong T, Parraga G, Buchanan D, Fenster A, House AA, Hackam DG,
Spence JD: Progression of carotid plaque volume predicts cardiovascular
events. Stroke; a Journal of Cerebral Circulation 2013, 44:1859–1865.
21. Prior PL, Hachinski V, Unsworth K, Chan R, Mytka S, O’Callaghan C,
Suskin N: Comprehensive cardiac rehabilitation for secondary
prevention after transient ischemic attack or mild stroke: I:
feasibility and risk factors. Stroke; a Journal of Cerebral Circulation
2011, 42:3207–3213.
22. Zigmond AS, Snaith RP: The hospital anxiety and depression scale.
Acta Psychiatr Scand 1983, 67:361–370.
23. Ware JE Jr, Kosinski M, Keller SD: A 12-item short-form health survey:
construction of scales and preliminary tests of reliability and validity.
Med Care 1996, 34:220–233.
24. Buchanan DN, Lindenmaier T, McKay S, Bureau Y, Hackam DG, Fenster A,
Parraga G: The relationship of carotid three-dimensional ultrasound
vessel wall volume with age and sex: comparison to carotid
intima-media thickness. Ultrasound Med Biol 2012, 38:1145–1153.
25. Selzer RH, Hodis HN, Kwong-Fu H, Mack WJ, Lee PL, Liu C-r, Liu C-h:
Evaluation of computerized edge tracking for quantifying intima-media
thickness of the common carotid artery from B-mode ultrasound images.
Atherosclerosis 1994, 111:1–11.
26. Buchanan D, Gyacskov I, Ukwatta E, Lindenmaier T, Fenster A, Parraga G:
Semi-automated segmentation of carotid artery total plaque volume
from three dimensional ultrasound carotid imaging. In Medical
Imaging 2012: Biomedical Applications in Molecular, Structural, and
Functional Imaging. Volume 8317. Edited by Molthen RC, Weaver JB.
2012. Proceedings of SPIE].
27. Ridker PM, Stampfer MJ, Rifai N: Novel risk factors for systemic
atherosclerosis. JAMA: the Journal of the American Medical Association 2001,
285:2481–2485.
doi:10.1186/1476-7120-11-39
Cite this article as: Lindenmaier et al.: One, two and three-dimensional
ultrasound measurements of carotid atherosclerosis before and
after cardiac rehabilitation: preliminary results of a randomized controlled
trial. Cardiovascular Ultrasound 2013 11:39.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lindenmaier et al. Cardiovascular Ultrasound 2013, 11:39 Page 11 of 11
http://www.cardiovascularultrasound.com/content/11/1/39
